|
1
|
Heerspink HJL, Parving HH, Andress DL,
Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H,
McMurray JJV, et al: Atrasentan and renal events in patients with
type 2 diabetes and chronic kidney disease (SONAR): A double-blind,
randomised, placebo-controlled trial. Lancet. 393:1937–1947.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bell S, Fletcher EH, Brady I, Looker HC,
Levin D, Joss N, Traynor JP, Metcalfe W, Conway B, Livingstone S,
et al: End-stage renal disease and survival in people with
diabetes: A national database linkage study. QJM. 108:127–134.
2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Verzola D, Cappuccino L, D'Amato E,
Villaggio B, Gianiorio F, Mij M, Simonato A, Viazzi F, Salvidio G
and Garibotto F: Enhanced glomerular Toll-like receptor 4
expression and signaling in patients with type 2 diabetic
nephropathy and microalbuminuria. Kidney Int. 86:1229–1243.
2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rossing P and Persson F: What have we
learned so far from the use of sodium-glucose cotransporter 2
inhibitors in clinical practice? Adv Chronic Kidney Dis.
28:290–297. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhu X, Tang L, Mao J, Hameed Y, Zhang J,
Li N, Wu D, Huang Y and Li C: Decoding the Mechanism behind the
pathogenesis of the focal segmental glomerulosclerosis. Comput Math
Methods Med. 2022(1941038)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tung CW, Hsu YC, Shih YH, Chang PJ and Lin
CL: Glomerular mesangial cell and podocyte injuries in diabetic
nephropathy. Nephrology (Carlton). 23 (Suppl 4):S32–S37.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Pi WX, Feng XP, Ye LH and Cai BC:
Combination of morroniside and diosgenin prevents high
glucose-induced cardiomyocytes apoptosis. Molecules.
22(163)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang WS, Moon SY, Lee MJ, Lee EK and Park
SK: Diosgenin, an activator of 1,25D3-MARRS receptor/ERp57,
attenuates the effects of TNF-α by causing ADAM10-dependent
ectodomain shedding of TNF receptor 1. Cell Physiol Biochem.
43:2434–2445. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Long C, Chen J, Zhou H, Jiang T, Fang X,
Hou D, Liu P and Duan H: Diosgenin exerts its tumor suppressive
function via inhibition of Cdc20 in osteosarcoma cells. Cell Cycle.
18:346–358. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kalailingam P, Kannaian B, Tamilmani E and
Kaliaperumal R: Efficacy of natural diosgenin on cardiovascular
risk, insulin secretion, and beta cells in streptozotocin
(STZ)-induced diabetic rats. Phytomedicine. 21:1154–1161.
2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hua S, Li Y, Su L and Liu X: Diosgenin
ameliorates gestational diabetes through inhibition of sterol
regulatory element-binding protein-1. Biomed Pharmacother.
84:1460–1465. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chiang SS, Chang SP and Pan TM:
Osteoprotective effect of Monascus-fermented dioscorea in
ovariectomized rat model of postmenopausal osteoporosis. J Agric
Food Chem. 59:9150–9157. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gan Q, Wang J, Hu J, Lou G, Xiong H, Peng
C, Zheng S and Huang Q: The role of diosgenin in diabetes and
diabetic complications. J Steroid Biochem Mol Biol.
198(105575)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang Z, Wu Q, Wang H, Gao Y, Nie K, Tang
Y, Su H, Hu M, Gong J, Fang K and Dong H: Diosgenin protects
against podocyte injury in early phase of diabetic nephropathy
through regulating SIRT6. Phytomedicine. 104(154276)2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Xue W, Mao J, Chen Q, Ling W and Sun Y:
Mogroside IIIE alleviates high glucose-induced inflammation,
oxidative stress and apoptosis of podocytes by the activation of
AMPK/SIRT1 signaling pathway. Diabetes Metab Syndr Obes.
13:3821–3830. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chen B, Li J and Zhu H: AMP-activated
protein kinase attenuates oxLDL uptake in macrophages through
PP2A/NF-κB/LOX-1 pathway. Vascul Pharmacol. 85:1–10.
2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li F, Chen Y, Li Y, Huang M and Zhao W:
Geniposide alleviates diabetic nephropathy of mice through
AMPK/SIRT1/NF-kappaB pathway. Eur J Pharmacol.
886(173449)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chen Y, Xu X, Zhang Y, Liu K, Huang F, Liu
B and Kou J: Diosgenin regulates adipokine expression in
perivascular adipose tissue and ameliorates endothelial dysfunction
via regulation of AMPK. J Steroid Biochem Mol Biol. 155:155–165.
2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Samsu N: Diabetic nephropathy: Challenges
in pathogenesis, diagnosis, and treatment. Biomed Res Int.
2021(1497449)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li F, Dai B and Ni X: Long non-coding RNA
cancer susceptibility candidate 2 (CASC2) alleviates the high
glucose-induced injury of CIHP-1 cells via regulating
miR-9-5p/PPARγ axis in diabetes nephropathy. Diabetol Metab Syndr.
12(68)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yang F, Qin Y, Wang Y, Meng S, Xian H, Che
H, Lv J, Li Y, Yu Y, Bai Y and Wang L: Metformin Inhibits the NLRP3
inflammasome via AMPK/mTOR-dependent effects in diabetic
cardiomyopathy. Int J Biol Sci. 15:1010–1019. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kumar P, Nagarajan A and Uchil PD:
Analysis of cell viability by the lactate dehydrogenase assay. Cold
Spring Harb Protoc 2018: doi: 10.1101/pdb.prot095497, 2018.
|
|
23
|
Zhan X, Yan C, Chen Y, Wei X, Xiao J, Deng
L, Yang Y, Qiu P and Chen Q: Celastrol antagonizes high
glucose-evoked podocyte injury, inflammation and insulin resistance
by restoring the HO-1-mediated autophagy pathway. Mol Immunol.
104:61–68. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li Y, Li Y, Yang T and Wang M: Dioscin
attenuates oxLDL uptake and the inflammatory reaction of dendritic
cells under high glucose conditions by blocking p38 MAPK. Mol Med
Rep. 21:304–310. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Li G, Huang D, Li N, Ritter JK and Li PL:
Regulation of TRPML1 channel activity and inflammatory exosome
release by endogenously produced reactive oxygen species in mouse
podocytes. Redox Biol. 43(102013)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wu S, Zhao M, Sun Y, Xie M, Le K, Xu M and
Huang C: The potential of Diosgenin in treating psoriasis: Studies
from HaCaT keratinocytes and imiquimod-induced murine model. Life
Sci. 241(117115)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Du S, Li C, Lu Y, Lei X, Zhang Y, Li S,
Liu F, Chen Y, Weng D and Chen J: Dioscin alleviates crystalline
silica-induced pulmonary inflammation and fibrosis through
promoting alveolar macrophage autophagy. Theranostics. 9:1878–1892.
2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Khosravi Z, Sedaghat R, Baluchnejadmojarad
T and Roghani M: Diosgenin ameliorates testicular damage in
streptozotocin-diabetic rats through attenuation of apoptosis,
oxidative stress, and inflammation. Int Immunopharmacol. 70:37–46.
2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Opazo-Rios L, Mas S, Marin-Royo G, Mezzano
S, Gómez-Guerrero C, Moreno JA and Egido J: Lipotoxicity and
diabetic nephropathy: Novel mechanistic insights and therapeutic
opportunities. Int J Mol Sci. 21(2632)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu K, Zhao W, Gao X, Huang F, Kou J and
Liu B: Diosgenin ameliorates palmitate-induced endothelial
dysfunction and insulin resistance via blocking IKKβ and IRS-1
pathways. Atherosclerosis. 223:350–358. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Naidu PB, Ponmurugan P, Begum MS, Mohan K,
Meriga B, RavindarNaik R and Saravanan G: Diosgenin reorganises
hyperglycaemia and distorted tissue lipid profile in high-fat
diet-streptozotocin-induced diabetic rats. J Sci Food Agric.
95:3177–3182. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lu J, Chen PP, Zhang JX, Li XQ, Wang GH,
Yuan BY, Huang SJ, Liu XQ, Jiang TT, Wang MY, et al: GPR43
deficiency protects against podocyte insulin resistance in diabetic
nephropathy through the restoration of AMPKalpha activity.
Theranostics. 11:4728–4742. 2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ran X, Yan Z, Yang Y, Hu G, Liu J, Hou S,
Guo W, Kan X and Fu S: Dioscin improves pyroptosis in LPS-induced
mice mastitis by activating AMPK/Nrf2 and inhibiting the NF-kappaB
signaling pathway. Oxid Med Cell Longev.
2020(8845521)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yao H, Tao X, Xu L, Qi Y, Yin L, Han X, Xu
Y, Zheng L and Peng J: Dioscin alleviates non-alcoholic fatty liver
disease through adjusting lipid metabolism via SIRT1/AMPK signaling
pathway. Pharmacol Res. 131:51–60. 2018.PubMed/NCBI View Article : Google Scholar
|
